Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−0.38EUR
−8.28 MEUR
55.34 MEUR
10.11 M
About BRAIN BIOTECH AG
Sector
Industry
CEO
Adriaan Moelker
Website
Headquarters
Zwingenberg
Employees (FY)
309
Founded
1993
FIGI
BBG00NRVY799
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. It operates through the BioScience and BioIndustrial segments. The BioScience segment works on enzymes and performance microorganisms; and collaborates with industrial partners. The BioIndustrial segment deals with the bioproduct and cosmetics businesses. The company was founded by Holger Zinke, Jüngen Eck, and Hans Günter Gassen on September 22, 1993 and is headquartered in Zwingenberg, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0RFI is 2.83 EUR — it has increased by 0.89% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BRAIN BIOTECH AG NPV stocks are traded under the ticker 0RFI.
BRAIN BIOTECH AG NPV is going to release the next earnings report on May 28, 2024. Keep track of upcoming events with our Earnings Calendar.
0RFI stock is 0.88% volatile and has beta coefficient of 0.09. Check out the list of the most volatile stocks — is BRAIN BIOTECH AG NPV there?
Yes, you can track BRAIN BIOTECH AG NPV financials in yearly and quarterly reports right on TradingView.
0RFI stock has fallen by 11.56% compared to the previous week, the month change is a 25.53% fall, over the last year BRAIN BIOTECH AG NPV has showed a 52.03% decrease.
0RFI net income for the last quarter is −3.48 M EUR, while the quarter before that showed −4.80 M EUR of net income which accounts for 27.41% change. Track more BRAIN BIOTECH AG NPV financial stats to get the full picture.
Today BRAIN BIOTECH AG NPV has the market capitalization of 62.92 M, it has decreased by 8.77% over the last week.
No, 0RFI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0RFI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRAIN BIOTECH AG NPV stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 309.00 employees. See our rating of the largest employees — is BRAIN BIOTECH AG NPV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRAIN BIOTECH AG NPV technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRAIN BIOTECH AG NPV stock shows the strong sell signal. See more of BRAIN BIOTECH AG NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BRAIN BIOTECH AG NPV future price: according to them, 0RFI price has a max estimate of 15.00 EUR and a min estimate of 4.10 EUR. Read a more detailed BRAIN BIOTECH AG NPV forecast: see what analysts think of BRAIN BIOTECH AG NPV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BRAIN BIOTECH AG NPV EBITDA is −2.49 M EUR, and current EBITDA margin is −3.72%. See more stats in BRAIN BIOTECH AG NPV financial statements.